These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16512577)

  • 21. Defender of the law. False Claims Act co-author to keep fighting healthcare fraud as Senate panel chair.
    Taylor M
    Mod Healthc; 2003 Jan; 33(1):32-3. PubMed ID: 12545527
    [No Abstract]   [Full Text] [Related]  

  • 22. Human subject protection: overkill?
    Kim PJ
    J Foot Ankle Surg; 2010; 49(4):317-8. PubMed ID: 20537567
    [No Abstract]   [Full Text] [Related]  

  • 23. Twenty-five years of health law through the lens of the civil false claims act.
    Krause JH
    Ann Health Law; 2010; 19(1 Spec No):13-7. PubMed ID: 21495540
    [No Abstract]   [Full Text] [Related]  

  • 24. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 25. Muriel Volpellier: confronting sexual violence with evidence.
    Alcorn T
    Lancet; 2014 Jun; 383(9934):2038. PubMed ID: 24923528
    [No Abstract]   [Full Text] [Related]  

  • 26. Your mission is ... academic fraud and theft are a growing problem as researchers struggle to keep to an ethical code that is never talked about. Now some of science's top names are taking up the fight to keep the profession honest.
    Cohen P
    New Sci; 1999 Jul; 162(2193):38-41. PubMed ID: 11657935
    [No Abstract]   [Full Text] [Related]  

  • 27. Secret treasure-troves restored.
    Nature; 2008 Jan; 451(7178):500. PubMed ID: 18235454
    [No Abstract]   [Full Text] [Related]  

  • 28. Approaches vary for clinical trials in developing countries.
    Hayasaka E
    J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687
    [No Abstract]   [Full Text] [Related]  

  • 29. John Bartlett and bioterrorism.
    Henderson DA
    Clin Infect Dis; 2014 Sep; 59 Suppl 2():S76-9. PubMed ID: 25151482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public health law in the new century.
    Reynolds C
    J Law Med; 2003 May; 10(4):435-41. PubMed ID: 12852317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

  • 32. Fair benefits in developing countries: maximin as a good start.
    Macklin R
    Am J Bioeth; 2010 Jun; 10(6):36-7. PubMed ID: 20526967
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sanctions against fraudsters and the situation of whistleblowers with respect to the law].
    Moret-Bailly J
    Presse Med; 2012 Sep; 41(9 Pt 1):867-71. PubMed ID: 22771024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why adopt a maximin theory of exploitation?
    Wertheimer A; Millum J; Schaefer GO
    Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
    [No Abstract]   [Full Text] [Related]  

  • 35. Using ethics to fight bioterrorism.
    Perman B
    Science; 2005 Aug; 309(5737):1012-7; author reply 1012-7. PubMed ID: 16106522
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple forms of exploitation in international research: the need for multiple standards of fairness.
    Snyder J
    Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969
    [No Abstract]   [Full Text] [Related]  

  • 37. [Increasing criminal insurance fraud is only partly detected by the law].
    Geerds F
    Versicherungsmedizin; 1993 Oct; 45(5):141-2. PubMed ID: 8256413
    [No Abstract]   [Full Text] [Related]  

  • 38. Human rights: the normative engine of fairness and research in developing countries.
    McMillan J
    Am J Bioeth; 2010 Jun; 10(6):47-9. PubMed ID: 20526973
    [No Abstract]   [Full Text] [Related]  

  • 39. [Methods of diagnosis and differentiation of plague pathogen: approaches to detection of atypical strains of Yersinia pestis by molecular biology. Part I].
    Trukhachev AL; Lebedeva SA
    Mol Gen Mikrobiol Virusol; 2006; (1):3-6. PubMed ID: 16512602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trials of a cancer doc. Experimental drugs and a 20-year fight with the FDA.
    Brownlee S
    US News World Rep; 1998 Oct; 125(13):28-30, 32, 35. PubMed ID: 10186429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.